Child psychosis study aims to match kids to the right drug

NCT ID NCT04370730

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is following 200 children and teens (ages 7-20) who have experienced psychosis to see if they fall into distinct subgroups. Researchers will use interviews, brain scans, and genetic tests to classify participants. The goal is to see if these subgroups predict how well a child responds to specific antipsychotic medications, potentially leading to more personalized treatment in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors identify which antipsychotic drug works best for a child based on their specific psychosis subtype, leading to more personalized treatment.
What could go wrong
This is an observational study, not a treatment trial. It may not lead to immediate changes in care, and the findings might not apply to all children with psychosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSYCHOTIC DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHRU de Lille

    NOT_YET_RECRUITING

    Lille, 59037, France

  • CHU de Nice

    NOT_YET_RECRUITING

    Nice, 62000, France

  • CHU de Rouen

    NOT_YET_RECRUITING

    Rouen, 76031, France

  • CHU de Rouvray

    NOT_YET_RECRUITING

    Rouen, 76031, France

  • Fondation Vallée, Gentilly

    NOT_YET_RECRUITING

    Gentilly, 94257, France

  • Pitié Salpétrière

    RECRUITING

    Paris, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.